Cognitive remediation therapy

BioTek reMEDys Celebrates the Pharmacy Professions for American Pharmacists Month

Retrieved on:

Tuesday, October 17, 2023

Biotechnology, General Health, Health, Pharmaceutical, Managed Care, BioTek, Pharmacist, Cognitive remediation therapy, American Pharmacists Association, Patient, Education, Pharmacy technician, Rare, Pharmacy, Physician, Pharmaceutical industry, Nursing

Annually celebrated during the month of October, American Pharmacists Month has been designated by the American Pharmacists Association as a time to recognize pharmacists’ contributions to health care and all they do for their communities.

Key Points:

Annually celebrated during the month of October, American Pharmacists Month has been designated by the American Pharmacists Association as a time to recognize pharmacists’ contributions to health care and all they do for their communities.
“American Pharmacists Month is a time to recognize the contributions and impact pharmacists, specialty pharmacists and pharmacy technicians make on patient wellbeing and on the healthcare system as a whole,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde.
BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.
Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.

BioTek reMEDys to Attend Immunoglobulin National Society Meeting

Retrieved on:

Thursday, October 5, 2023

Biotechnology, General Health, Health, Pharmaceutical, Managed Care, Certification, Knowledge, BioTek, Physician, Nursing, Pharmacist, Cognitive remediation therapy, Rare, Patient, Health literacy, Pharmaceutical industry, IGN FI

As part of its commitment to expand upon health literacy and explore best practices in the immunoglobulin therapy space, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, has sent its team of Immunoglobulin National Society (IgNS) certified pharmacists to this week’s IgNS 2023 annual national conference in Denver for the latest clinical education and practice advancements with patients and colleagues.

Key Points:

As part of its commitment to expand upon health literacy and explore best practices in the immunoglobulin therapy space, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, has sent its team of Immunoglobulin National Society (IgNS) certified pharmacists to this week’s IgNS 2023 annual national conference in Denver for the latest clinical education and practice advancements with patients and colleagues.
The Immunoglobulin National Society is a professional organization dedicated to the advancement of immunoglobulin therapy practice, across clinical indications and areas of practice.
The mission of IgNS is to:
“We’re proud to be long-time supporters of the Immunoglobulin National Society and are excited to be participating this year by sending our pharmacist colleagues to the annual event,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde.
Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.

BioTek reMEDys Calls for Heightened Communication Around Health Literacy Month

Retrieved on:

Wednesday, October 4, 2023

Family, Health, Consumer, Women, Seniors, General Health, Men, Communication, Cognitive remediation therapy, Pharmacist, Rare, Hospital, Physician, Health literacy, Patient, Erythema ab igne, BioTek, Pharmaceutical industry, Nursing

With October being Health Literacy Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for greater emphasis on communication to improve optimal health literacy.

Key Points:

With October being Health Literacy Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for greater emphasis on communication to improve optimal health literacy.
For more than 20 years, October has been recognized as Health Literacy Month.
To participate this year, BioTek is proactively promoting the observance among patients, patient loved ones, colleagues, pharmacists, hospitals, health centers, and other groups working together to integrate and expand the mission of health literacy.
“While it’s something we focus on year round, during Health Literacy Month we work to further promote our efforts to encourage patients and patient families to put health literacy awareness into action,” said BioTek reMEDys’ CEO and founder Chaitanya Gadde.

BioTek reMEDys Calls for Increased Awareness Around Juvenile Arthritis Awareness and Education

Retrieved on:

Wednesday, August 30, 2023

BioTek reMEDys is urging its clinical and patient constituents and the population at large to become more aware and get involved.

Key Points:

BioTek reMEDys is urging its clinical and patient constituents and the population at large to become more aware and get involved.
To draw awareness to the condition, BioTek reMEDys is also encouraging people to share their experiences on the National Psoriasis Action Month website .
BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.
Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.

BioTek reMEDys Calls for Increased Juvenile Arthritis Awareness and Education

Retrieved on:

Wednesday, July 19, 2023

With July being Juvenile Arthritis Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.

Key Points:

With July being Juvenile Arthritis Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.
An estimated 300,000 children in the US are affected by some form of Juvenile Arthritis (JA).
BioTek reMEDys is urging its clinical and patient constituents and the population at large to become more aware and get involved via national resources such as the Arthritis Foundation .
To draw awareness to the condition, BioTek reMEDys is also encouraging people to share their stories online or via social media with the hashtag #StrongerThanJA.

BioTek reMEDys Calls for Increased Huntington’s Disease Awareness and Education

Retrieved on:

Wednesday, May 17, 2023

With May being Huntington’s Disease Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.

Key Points:

With May being Huntington’s Disease Awareness Month, BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is calling for enhanced education and awareness of the condition.
BioTek reMEDys is urging its clinical and patient constituents and the population at large to become more aware and get involved via national resources such as the Huntington’s Disease Society of America.
To draw awareness to the often underdiagnosed condition, BioTek reMEDys is also encouraging people to post photos of themselves wearing blue with the hashtag #LetsTalkAboutHD on social media.
By servicing very specific disease states such as HD, BioTek reMEDys’ expert team maintains its focus on patient care – making sure that dosages and treatments are appropriate.

BioTek reMEDys Featured as a Corporate Member of the Month by National Association of Specialty Pharmacy

Retrieved on:

Tuesday, March 7, 2023

Health, Healthcare Reform, Pharmaceutical, Public Policy, Government, Managed Care, Specialty pharmacy, DE, Pharmacy, Patient, Employee of the month (program), NASP, System, Cognitive remediation therapy, National Association, Hospital, Nursing, BioTek

BioTek reMEDys , one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, was honored this week by the National Association of Specialty Pharmacy ( NASP ) to receive a March Corporate Member Spotlight as part of the NASP Spotlight Corporate Members of the Month Program.

Key Points:

BioTek reMEDys , one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, was honored this week by the National Association of Specialty Pharmacy ( NASP ) to receive a March Corporate Member Spotlight as part of the NASP Spotlight Corporate Members of the Month Program.
“We are honored to be recognized by our peers and colleagues in the specialty pharmacy space as a leading organization in the field,” said Chai Gadde, CEO and founder of BioTek reMEDys.
Founded in 2011, BioTek reMEDys, based in New Castle, DE, has become one of the nation’s largest independent infusion pharmacies focused on home infusion.
Chai Gadde opened the pharmacy to meet the specific needs of patients who require specialty medications.

BioTek reMEDys Celebrates National IV Nurse Day

Retrieved on:

Wednesday, January 25, 2023

In honor of today being National IV Nurse Day, BioTek reMEDys , one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of safe medication use for patients with rare diseases and conditions, while also celebrating and drawing attention to the tremendous contributions of IV Nurses nationwide.

Key Points:

In honor of today being National IV Nurse Day, BioTek reMEDys , one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of safe medication use for patients with rare diseases and conditions, while also celebrating and drawing attention to the tremendous contributions of IV Nurses nationwide.
Founded by the Infusion Nurse Society , an international nonprofit organization representing infusion nurses and other clinicians who are engaged in the specialty practice of infusion therapy, National IV Nurse Day is celebrated each year on January 25th to recognize the decades of continuing education, advocacy, and professional development that have driven the infusion specialty.
“National IV Nurse Day is a time to recognize the vital contributions and powerful impact these professionals – who we proudly work alongside on a daily basis – have on the patient population, and on the healthcare system as a whole.
To learn more about National IV Nurse Day, visit ins1.org/about-us/iv-nurse-day .

BioTek reMEDys Promotes Awareness and Education for Autoinflammatory Conditions

Retrieved on:

Tuesday, August 30, 2022

In honor of August being International Autoinflammatory Awareness Month, BioTek reMEDys , one of the nations largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of these rare diseases and conditions.

Key Points:

In honor of August being International Autoinflammatory Awareness Month, BioTek reMEDys , one of the nations largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of these rare diseases and conditions.
BioTek reMEDys is urging its colleagues, patients, and the population at large to become more aware and help drive education regarding these conditions.
Because many autoimmune conditions are statistically rare, they can often be misdiagnosed and we hope to help shine a light on the importance of education about these conditions, said Andrew Babb, PharmD, BioTek reMEDys Pharmacist in Charge.
By servicing very specific disease states such autoinflammatory conditions, BioTek reMEDys expert team can maintain its focus on patient care making sure that dosages and treatments are appropriate.

The Dorm to Provide State-of-the-Art Treatment for Young Adults with Expanded Program in Washington, D.C.

Retrieved on:

Thursday, March 31, 2022

WASHINGTON, March 31, 2022 /PRNewswire/ -- The Dorm, a young adult mental health treatment community that has been supporting the needs of youth in the DMV region since 2018, has announced the expansion of its Washington, D.C. location at Dupont Circle, which will open in April 2022. Housed in the heart of the city, the new space will provide D.C.'s population of young adults with a fresh and lively treatment experience with state-of-the-art clinical amenities. This move comes in response to an increased strain on local resources and growing demand for local mental health treatment.

Key Points:

Housed in the heart of the city, the new space will provide D.C.'s population of young adults with a fresh and lively treatment experience with state-of-the-art clinical amenities.
This move comes in response to an increased strain on local resources and growing demand for local mental health treatment.
"There is an urgent need for young adult mental health resources not only at home here in D.C., but also across America."
Since 2009, our mission has been to guide young adults towards independence through evidence-based clinical therapies, community support and practical skill-building.